Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orvepitant DDI with Itraconazole in Healthy Males
NCT03535662Phase 1Completed
- Sponsor
- NeRRe Therapeutics
- Start
- Jun 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of orvepitant in chronic cough (2 arms), sponsored by NeRRe Therapeutics. Primary endpoint: Exposure to orvepitant. Started Jun 2018; status: completed.
02
Drugs
orvepitant
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT03535662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535662.